» Articles » PMID: 34020704

Mesenchymal Stem/stromal Cell-derived Exosomes in Regenerative Medicine and Cancer; Overview of Development, Challenges, and Opportunities

Abstract

Recently, mesenchymal stem/stromal cells (MSCs) and their widespread biomedical applications have attracted great consideration from the scientific community around the world. However, reports have shown that the main populations of the transplanted MSCs are trapped in the liver, spleen, and lung upon administration, highlighting the importance of the development of cell-free therapies. Concerning rising evidence suggesting that the beneficial effects of MSC therapy are closely linked to MSC-released components, predominantly MSC-derived exosomes, the development of an MSC-based cell-free approach is of paramount importance. The exosomes are nano-sized (30-100 nm) lipid bilayer membrane vesicles, which are typically released by MSCs and are found in different body fluids. They include various bioactive molecules, such as messenger RNA (mRNA), microRNAs, proteins, and bioactive lipids, thus showing pronounced therapeutic competence for tissues recovery through the maintenance of their endogenous stem cells, the enhancement of regenerative phenotypic traits, inhibition of apoptosis concomitant with immune modulation, and stimulation of the angiogenesis. Conversely, the specific roles of MSC exosomes in the treatment of various tumors remain challenging. The development and clinical application of novel MSC-based cell-free strategies can be supported by better understanding their mechanisms, classifying the subpopulation of exosomes, enhancing the conditions of cell culture and isolation, and increasing the production of exosomes along with engineering exosomes to deliver drugs and therapeutic molecules to the target sites. In the current review, we deliver a brief overview of MSC-derived exosome biogenesis, composition, and isolation methods and discuss recent investigation regarding the therapeutic potential of MSC exosomes in regenerative medicine accompanied by their double-edged sword role in cancer.

Citing Articles

Targeting Neuroinflammation in Preterm White Matter Injury: Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes.

Zhang X, Zhang Y, Peng X, Yang L, Miao J, Yue Y Cell Mol Neurobiol. 2025; 45(1):23.

PMID: 40072734 PMC: 11903990. DOI: 10.1007/s10571-025-01540-6.


Multiple Intra-Articular Injections of Adipose-Derived Mesenchymal Stem Cells for Canine Osteoarthritis Treatment.

Li X, Jian X, Yan Z, Liu H, Zhang L Cells. 2025; 14(5).

PMID: 40072052 PMC: 11899304. DOI: 10.3390/cells14050323.


Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells.

Balaraman A, Babu M, Afzal M, Sanghvi G, M M R, Gupta S Regen Ther. 2025; 28:558-572.

PMID: 40034540 PMC: 11872554. DOI: 10.1016/j.reth.2025.01.019.


Advances of exosomes in diabetic wound healing.

Jin W, Li Y, Yu M, Ren D, Han C, Guo S Burns Trauma. 2025; 13:tkae078.

PMID: 39980588 PMC: 11836438. DOI: 10.1093/burnst/tkae078.


Exosome: an overview on enhanced biogenesis by small molecules.

Bavafa A, Izadpanahi M, Hosseini E, Hajinejad M, Abedi M, Forouzanfar F Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39862264 DOI: 10.1007/s00210-024-03762-9.


References
1.
Ma Y, Dong L, Zhou D, Li L, Zhang W, Zhen Y . Extracellular vesicles from human umbilical cord mesenchymal stem cells improve nerve regeneration after sciatic nerve transection in rats. J Cell Mol Med. 2019; 23(4):2822-2835. PMC: 6433678. DOI: 10.1111/jcmm.14190. View

2.
Forsberg M, Kink J, Hematti P, Capitini C . Mesenchymal Stromal Cells and Exosomes: Progress and Challenges. Front Cell Dev Biol. 2020; 8:665. PMC: 7379234. DOI: 10.3389/fcell.2020.00665. View

3.
Almeria C, Weiss R, Roy M, Tripisciano C, Kasper C, Weber V . Hypoxia Conditioned Mesenchymal Stem Cell-Derived Extracellular Vesicles Induce Increased Vascular Tube Formation . Front Bioeng Biotechnol. 2019; 7:292. PMC: 6819375. DOI: 10.3389/fbioe.2019.00292. View

4.
Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View

5.
Li J, Wei L, Han Z, Chen Z . Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol. 2019; 852:68-76. DOI: 10.1016/j.ejphar.2019.01.022. View